• 1
    Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J 2006; 151: 18591.
  • 2
    Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 1918.
  • 3
    Van Hees PA, Van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982; 4: 3336.
  • 4
    Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment Pharmacol Ther 2003; 17: 6973.
  • 5
    Lopez San Roman A, Bermejo F, Carrera E, Perez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005; 97: 24957.
  • 6
    Bernal I, Marín L, Garcia-Planella E, et al. Cumplimiento terapéutico y automediación en una cohorte de pacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2005; 28: 145.
  • 7
    Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 153544.
    Direct Link:
  • 8
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW. Cardiovascular morbidity associated with non adherence to statin therapy. Pharmacotherapy 2005; 25: 103543.
  • 9
    Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114: 3943.
  • 10
    Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995; 30: 16470.
  • 11
    Eaden J. Review article: The data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 (Suppl. 2): 1521.
  • 12
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 48797.
  • 13
    Shaw IS, Jobson BA, Silverman D, et al. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds. Aliment Pharmacol Ther 2002; 16: 20539.
  • 14
    Lopez-Sanroman A, Bermejo F, Carrera E, Garcia-Plaza A. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1616.
  • 15
    Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003; 1: 1703.
  • 16
    Robinson A. Review article: Inflammatory bowel disease – empowering the patient and improving outcome. Aliment Pharmacol Ther 2004; 20 (Suppl. 4): 847.
  • 17
    Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 14709.
    Direct Link:
  • 18
    Maunder RG, Lancee WJ, Hunter JJ, Greenberg GR, Steinhart AH. Attachment insecurity moderates the relationship between disease activity and depressive symptoms in ulcerative colitis. Inflamm Bowel Dis 2005; 11: 91926.
  • 19
    Maunder R, Toner B, De Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol 1999; 13: 72832.
  • 20
    Martin A, Leone L, Castagliuolo I, Di Mario F, Naccarato R. What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol 1992; 24: 47780.
  • 21
    Maunder R, Esplen MJ. Facilitating adjustment to inflammatory bowel disease: a model of psychosocial intervention in non-psychiatric patients. Psychother Psychosom 1999; 68: 23040.
  • 22
    Odes HS. 5-Aminosalicylic acid, 1,000-mg caplets versus 500-mg tablets, in maintenance of remission in ulcerative colitis. J Clin Gastroenterol 1997; 24: 2878.
  • 23
    Cawdron R, Issenman RM. Patient web-resource interest and Internet readiness in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002; 35: 51821.
  • 24
    Panes J, De Lacy AM, Sans M, Soriano A, Pique JM. Elevado índice de consultas por Internet de los pacientes catalanes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2001; 25: 3069.